• Scientists<img src="https://images.aposto.com/2021/11/3/1638324736145.jpeg" style="display: block; float: none; vertical-align: top; margin: 5px auto; text-align: center; width: 100%; max-width: 550px; border-style: none; position: relative; cursor: pointer; padding: 0px 1px; box-sizing: border-box;" ratio="1.58" width="550" alt="Covid vaccine" fr-original-style="display: block; float: none; vertical-align: top; margin: 5px auto; text-align: center; width: 100%; max-width: 550px;" fr-original-class="fr-draggable">via Reuters<ul fr-original-style="padding-inline-start: 20px;" style="padding-inline-start: 20px; margin-top: 0px; margin-bottom: 1em; list-style-position: inside; box-sizing: border-box;"><li fr-original-style="" style="box-sizing: border-box;">WHO said blanket travel bans will not help to prevent the international spread but will, instead, place a heavy burden on lives and livelihoods. Meanwhile, they acknowledged the use of screening measures to help curb the spread of the new Omicron variant.</li><li fr-original-style="" style="box-sizing: border-box;">Moderna’s CEO&nbsp;said that current vaccines would be less effective against the Omicron variant, a comment that raised alarming questions. Responding to this, other drug companies and epidemiologists emphasized that it is too early to say how dangerous Omicron could be or how effective current vaccines will be.</li><li fr-original-style="" style="box-sizing: border-box;">BioNTech’s CEO said that their vaccine was likely to offer strong protection against severe disease from Omicron.</li><li fr-original-style="" style="box-sizing: border-box;">The European Medicines Agency (EMA) said it could approve vaccines adapted to target the Omicron variant of the coronavirus within three to four months if needed, but that existing shots would continue to provide protection.</li><li fr-original-style="" style="box-sizing: border-box;">University of Oxford said there was no evidence that current vaccines would not prevent severe disease from Omicron but that, if necessary, they are ready to rapidly update their shot developed with AstraZeneca.</li></ul>

University of Oxford ile ilgili hikayeler